Clovis Oncology (CLVS) Tops Q1 EPS by 15c

Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($1.33), $0.15 better than the analyst estimate of ($1.48). Revenue for the quarter came in at $7.05 million versus the consensus estimate of $4.89 million.

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M